December 2018 Briefing – Otolaryngology

Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for December 2018. This roundup includes the latest research news from journal articles, as […]

Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Low-Priced Generic Drugs Most Likely to Have Shortages

THURSDAY, Dec. 27, 2018 (HealthDay News) — The lowest-priced generic drugs are more likely to experience shortages, according to a study published in the November issue of Value in Health.

Abstract/Full Text (subscription or payment may be required)

Initiative Can Cut Gender Gap in Medical School Faculty Salaries

WEDNESDAY, Dec. 26, 2018 (HealthDay News) — An institutional gender equity initiative (GEI) can reduce gender-based salary gaps among medical school faculty, according to a study published online Dec. 21 in JAMA Network Open.

Abstract/Full Text

New AAP Guideline Available for Infantile Hemangioma Treatment

WEDNESDAY, Dec. 26, 2018 (HealthDay News) — The American Academy of Pediatrics has developed its first guideline for the management of infantile hemangiomas (IHs); the clinical practice guideline was published online Dec. 24 in Pediatrics.

Abstract/Full Text

Affordable Care Act Sign-Ups Higher Than Expected

THURSDAY, Dec. 20, 2018 (HealthDay News) — Despite numerous difficulties, early figures show that sign-ups for health coverage next year under the Affordable Care Act are higher than expected.

AP News Article

Growth in Use of Telemedicine Seen From 2005 to 2017

THURSDAY, Dec. 20, 2018 (HealthDay News) — From 2005 to 2017, there was a substantial increase in telemedicine use, although use was still uncommon in 2017, according to a research letter published online Nov. 27 in the Journal of the American Medical Association.

Abstract/Full Text

Pembrolizumab Promising for Metastatic Head, Neck SCC

THURSDAY, Dec. 20, 2018 (HealthDay News) — For patients with recurrent or metastatic head and neck squamous cell carcinoma, pembrolizumab has a favorable safety profile and is associated with prolongation of overall survival, according to a study published online Nov. 30 in The Lancet.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Exclusion of Doctors From Public Health Insurance Up 2007 to 2017

TUESDAY, Dec. 18, 2018 (HealthDay News) — From 2007 to 2017, the number of physicians excluded from Medicare and state public insurance programs increased, according to a study published online Dec. 14 in JAMA Network Open.

Abstract/Full Text

Solriamfetol Feasible for Sleep Apnea-Related Tiredness

MONDAY, Dec. 17, 2018 (HealthDay News) — Solriamfetol therapy, compared with placebo, results in improvements in wakefulness and sleepiness measures in patients with excessive sleepiness due to obstructive sleep apnea (OSA), according to a study published online Dec. 6 in the American Journal of Respiratory and Critical Care Medicine.

1 | 2 | 3
Page 1 of 3
Next »